Apotheca Biosciences Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $0.08
50-Day Range
MA: $0.05
52-Week Range
Now: $0.08
Volume2,400 shs
Average Volume20,137 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry in the United States. The company's products include transdermal, sublingual, and nasal delivery devices for dosing of cannabinoids. It also provides CBD pain cream, gel capsules, patches, and sleep tablets; and Promed, anti-aging and cosmetic products. The company was incorporated in 2014 and is based in Saint Petersburg, Florida.
Apotheca Biosciences logo

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolNASDAQ:CBDC
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.42 out of 5 stars

Medical Sector

1710th out of 2,011 stocks

Biotechnology Industry

99th out of 143 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CBDC News and Ratings via Email

Sign-up to receive the latest news and ratings for CBDC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Apotheca Biosciences (NASDAQ:CBDC) Frequently Asked Questions

What stocks does MarketBeat like better than Apotheca Biosciences?

Wall Street analysts have given Apotheca Biosciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Apotheca Biosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Apotheca Biosciences' stock price been impacted by Coronavirus?

Apotheca Biosciences' stock was trading at $0.0190 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CBDC stock has increased by 294.7% and is now trading at $0.0750.
View which stocks have been most impacted by COVID-19

Who are Apotheca Biosciences' key executives?

Apotheca Biosciences' management team includes the following people:
  • Mr. Craig Huffman, Legal Council
  • Ms. Karin Rohret, Sec.

Who are some of Apotheca Biosciences' key competitors?

What other stocks do shareholders of Apotheca Biosciences own?

What is Apotheca Biosciences' stock symbol?

Apotheca Biosciences trades on the NASDAQ under the ticker symbol "CBDC."

How do I buy shares of Apotheca Biosciences?

Shares of CBDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apotheca Biosciences' stock price today?

One share of CBDC stock can currently be purchased for approximately $0.08.

How many employees does Apotheca Biosciences have?

Apotheca Biosciences employs 3 workers across the globe.

What is Apotheca Biosciences' official website?

The official website for Apotheca Biosciences is

How can I contact Apotheca Biosciences?

The company can be reached via phone at 727-228-3994.

This page was last updated on 4/11/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.